Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y

Neuroscience

Volumn 110, Issue 2, 2002, Pages 237-243

  Vezzani, A ^a   Michalkiewicz, M ^b   Michalkiewicz, T ^b   Moneta, D ^a   Ravizza, T ^a   Richichi, C ^a   Aliprandi, M ^a   Mule F ^a   Pirona, L ^a   Gobbi, M ^a   Schwarzer, C ^c   Sperk, G ^c  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Anticonvulsant; Epilepsy; Hippocampus; Kainic acid; Kindling; Limbic system

Indexed keywords

KAINIC ACID; MESSENGER RNA; NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTRICITY; ELECTROENCEPHALOGRAPHY; EPILEPTOGENESIS; GENE; GENE CONTROL; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HIPPOCAMPUS; KINDLING; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; SEIZURE; SEIZURE SUSCEPTIBILITY; TRANSGENIC ANIMAL; TREATMENT PLANNING; WILD TYPE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPSY, TEMPORAL LOBE; EXCITATORY AMINO ACID AGONISTS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HIPPOCAMPUS; KINDLING, NEUROLOGIC; MALE; NEURONS; NEUROPEPTIDE Y; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; UP-REGULATION;

EID: 0037066064     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00581-4     Document Type: Article

References (44)

1. Hippocampal formation
2. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y
3. Regulation of the release of coexisting neurotransmitters
4. Neuropeptide Y reduces epileptiform discharges and excitatory synaptic transmission in rat frontal cortex in vitro
5. Investigations into neuropeptide Y-mediated presynaptic inhibition in cultured hippocampal neurones of the rat
6. Decreased levels of neuropeptide Y(5) receptor binding sites in two experimental models of epilepsy
7. Effects of neuropeptide Y on eletrical properties of neurons
8. Experimentally induced attenuation of neuropeptide Y gene expression in transgenic mice increases mortality rate following seizures
9. 3-36 as selective Y1 and Y2 radioligands
10. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y
11. Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy
12. Anticonvulsant properties of BIBP3226, a non-peptide selective antagonist at neuropeptide Y Y1 receptors
13. Distinct changes in peptide YY binding to, and mRNA levels of, Y1 and Y2 receptors in the rat hippocampus associated with kindling epileptogenesis
14. Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro
15. Neuropeptide Y5 receptors reduce synaptic excitation in proximal subiculum, but not epileptiform activity in rat hippocampal slices
16. Neuropeptide Y: Some viewpoints on a multifaceted peptide in the normal and diseased nervous system
17. On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro
18. Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro
19. 1 receptors in kainic acid induced epilepsy in rats
20. Differential regulation of mRNAs for neuropeptide Y and its receptor subtypes in widespread areas of the rat limbic system during kindling epileptogenesis
21. Role of the Y5 neuropeptide Y receptor in limbic seizures
22. Developing transgenic neuropeptide Y rats
23. Increased blood pressure responses in neuropeptide Y transgenic rats
24. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors
25. NPY inhibits glutamatergic excitation in the epileptic human dentate gyrus
26. Modification of seizure activity by electrical stimulation, II. Motor seizure
27. Multiple receptors for neuropeptide Y in the hippocampus: Putative roles in seizures and cognition
28. Endogenous control of hippocampal epileptogenesis. A molecular cascade involving brain-derived neurotrophic factor and neuropeptide Y
29. Electrical kindling of the hippocampus is associated with functional activation of neuropeptide Y-containing neurons
30. Fluoro-Jade: A novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration
31. 2 receptors in an animal model of temporal lobe epilepsy
32. Neuropeptides-immunoreactivity and their mRNA expression in kindling: Functional implications for limbic epileptogenesis
33. Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy
34. Inhibitory effect of NPY on the picrotoxin-induced activity in the hippocampus: A behavioural and electrophysiological study
35. Functional changes in neuropeptide Y and somatostatin containing neurons induced by limbic seizures in the rat
36. Behavioral insensitivity to restrain stress, absent fear suppression of behavior and impaired spatial learning in neuropeptide Y transgenic rats
37. Enhanced neuropeptide Y release in the hippocampus is associated with chronic seizure susceptibility in kainic acid treated rats
38. Brain-derived neurotrophic factor immunoreactivity in the limbic system of rats after acute seizures and during spontaneous convulsions: Temporal evolution of changes as compared to neuropeptide Y
39. Modulatory role of neuropeptides in seizures induced in rats by stimulation of glutamate receptors
40. Somatostatin and its octapeptide analog SMS 201-995 modulate seizures induced by quinolinic and kainic acids differently in the rat hippocampus
41. Neuropeptide Y: Emerging evidence for a functional role in seizure modulation
42. 5-like receptors
43. Neuropeptide Y inhibits hippocampal seizures and wet dog shakes